Page last updated: 2024-08-21

indazoles and Emesis

indazoles has been researched along with Emesis in 73 studies

Research

Studies (73)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (9.59)	18.7374
1990's	57 (78.08)	18.2507
2000's	2 (2.74)	29.6817
2010's	6 (8.22)	24.3611
2020's	1 (1.37)	2.80

Authors

Authors	Studies
Chin, S; Choi, JW; Kim, SG; Kim, YS; Yoo, JJ	1
Gunderson, CC; Matulonis, U; Moore, KN	1
O'Cearbhaill, RE	1
Berardi, R; Burattini, L; Cascinu, S; Conti, A; De Giorgi, U; Iacovelli, R; Muzzonigro, G; Pantano, F; Santini, D; Santoni, M	1
Arnold, JK; Edison, LA; Gerona, RR; Schwartz, MD; Steck, AR; Trecki, J	1
Brown, AP; Courtney, CL; Criswell, KA; Evering, W; Holliman, CL; Jessen, BA	1
Dowlati, A; Gibson, DM; Hodge, JP; Hurwitz, HI; Merkle, EM; Pandite, L; Saini, S; Savage, S; Suttle, AB	1
Chowbay, B; Gao, F; Goh, BC; Ivy, P; Koh, TS; Leong, SS; Lim, WT; Ng, QS; Singh, O; Tan, DS; Tan, EH; Thng, CH; Toh, CK	1
Andrews, L; Fishman, M; Gorbunova, V; Jonasch, E; Larkin, J; Negrier, S; Olivier, K; Pyle, L; Staehler, M; Wood, L	1
Dott, CS; Joss, RA	1
Smith, IE	2
Angel, I; Garreau, M; Langer, SZ; Prouteau, M; Schoemaker, H	1
de Wet, M; Falkson, G; Rapoport, BL	1
Fukunaka, N; Ishioka, S; Itoh, E; Kitajima, Y; Kudo, R; Sagae, S; Sato, K	1
Furue, H; Niitani, H; Ogawa, N; Ohta, K; Suminaga, M; Taguchi, T	2
Gondo, H; Harada, M; Matsuishi, H; Omori, F; Otsuka, T; Shibuya, T; Taniguchi, S; Teshima, T; Yamano, Y; Yamazaki, K	1
Aapro, MS	1
Mori, K; Suga, Y; Takahashi, T; Tominaga, K	1
Hiraoka, A; Kageyama, T; Kakishita, E; Masaoka, T; Matsuzawa, Y; Nagai, K; Okuda, K; Oshiba, S; Tatsumi, N; Uchino, H	1
Cline, JM; Page, RL; Price, GS; Riviere, JE; Thrall, DE	1
Endo, T; Hagihara, K; Hamaue, N; Hirafuji, M; Minami, M; Monma, Y; Ogawa, T; Tamakai, H; Yoshioka, M	1
Baù, MG; Berruti, A; Bottini, A; Buniva, T; Danese, S; Dogliotti, L; Farris, A; Moro, G; Porcile, G; Richiardi, G; Zola, P	1
Airey, JE; Campbell, HF; Darkes, P; Fitzpatrick, LR; Klein, S; Neuenschwander, K; Pendley, CE; Powers, M; Schnapper, M; Youssefyeh, RD	1
Aguerri, MF; Alby, N; Giacchetti, S; Imbeaux, PH	1
Bremer, K	1
Marty, M	2
Blijham, GH	1
Andrews, PL; Bhandari, P; Bingham, S; Blower, PR; Davey, PT; Marr, HE	1
Diehl, V	1
Hacking, A	1
Dilly, S	1
Kamanabrou, D	1
Andrews, PL; Bingham, S; Joel, SP; Patel, N; Slevin, ML; Thompson, PI	1
Blijham, GH; Bots, MW; Dijkstra, HJ; Fehmers, MC; Keizer, HJ; Nortier, JW; Siegenbeek van Heukelom, L; Slee, PH; van der Wall, E; Veenhof, CH	1
Kaizer, L; Laberge, F; Latreille, J; O'Connell, G; Osoba, D; Pater, J; Stewart, D; Venner, P; Warr, D; Wilan, A	1
Bosanquet, N; Jones, AL; Lee, GJ	1
Aapro, M; Diehl, V; Kaye, SB; Khayat, D	1
Ito, T; Kato, S; Omoya, H; Yoshida, N	1
Butler, M; Collis, C; Coumar, A; Gandhi, L; Hamon, M; Hunter, AE; Murdoch, R; Pothecary, K; Prentice, HG; Upward, J	1
Davis, A; Erlichman, C; Fine, S; Laberge, F; Lofters, W; Osoba, D; Rusthoven, J; Warr, D; Willan, A; Wilson, K	1
Hunter, RD; Logue, JP; Magee, B; Murdoch, RD	1
Amaral, D; Lemerle, J; Murdoch, RD; Southall, DP; Upward, J	1
Andrews, PL; Bhandari, P	1
de Mulder, PH; Seynaeve, C; Verweij, J	1
Goa, KL; Plosker, GL	1
Gandara, DR; Hesketh, PJ	1
Falkson, CI; Falkson, G; Falkson, HC	1
Addelman, M; Erlichman, C; Fine, S; Murray, C; Warr, D	1
Nakao, I	1
King, GL	1
Airey, JE; Bostwick, JS; Decktor, DL; Fitzpatrick, LR; Gessner, GW; Lambert, RM; Martin, GE; Pendleton, RG; Pendley, CE; Youssefyeh, RD	1
Soukop, M	1
Brand, BC; Buser, KS; Cerny, T; Joss, RA	1
Caubel, M; Cupissol, DR; Serrou, B	1
Chevallier, B	1
Tabona, MV	1
Blower, PR	1
Pintens, H	1
Brown, GW; Butcher, ME; Kidgell, AE	1
Maher, M	1
Button, D	1
Falkson, G; van Zyl, AJ	1
Bhandari, P; Gupta, YK; Seth, SD	1
Brunner, K; Buser, K; Joss, R; Karde, C; Pirovino, M; Rohrbach, D	1
Brunner, KW; Joss, RA; Pirovino, M; Richner, J; Rohrbach, D; Terrey, JP; Upward, J	1
Bermudez, J; Boyle, EA; Miner, WD; Sanger, GJ	1
Adams, L; Cassidy, J; Kaye, SB; Lewis, C; Raina, V; Rankin, EM; Rapeport, WG; Soukop, M; Zussman, BD	1

Reviews

10 review(s) available for indazoles and Emesis

Article	Year
Management of the toxicities of common targeted therapeutics for gynecologic cancers. Gynecologic oncology, 2018, Volume: 148, Issue:3 Topics: Anemia; Angiogenesis Inhibitors; Antineoplastic Agents, Immunological; Autoimmune Diseases; Bevacizumab; Diarrhea; Epistaxis; Fatigue; Female; Genital Neoplasms, Female; Headache; Hemorrhage; Humans; Hypertension; Indazoles; Intestinal Perforation; Molecular Targeted Therapy; Nausea; Neutropenia; Poly(ADP-ribose) Polymerase Inhibitors; Precision Medicine; Proteinuria; Pyrimidines; Risk Assessment; Sulfonamides; Vomiting; Water-Electrolyte Imbalance	2018
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials. International journal of cancer, 2014, Aug-15, Volume: 135, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Carcinoma, Renal Cell; Clinical Trials as Topic; Diarrhea; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Incidence; Indazoles; Indoles; Liver Neoplasms; Neoplasms; Niacinamide; Phenylurea Compounds; Pyrimidines; Pyrroles; Sorafenib; Sulfonamides; Sunitinib; Vomiting	2014
Review of experience with ondansetron and granisetron. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4 Suppl 3 Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting	1993
Are granisetron and ondansetron equivalent in the clinic? European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1 Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Imidazoles; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting	1992
5-HT3 receptor antagonists, a new approach in emesis: a review of ondansetron, granisetron and tropisetron. Anti-cancer drugs, 1991, Volume: 2, Issue:4 Topics: Animals; Antiemetics; Granisetron; Humans; Imidazoles; Indazoles; Indoles; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting	1991
Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic. Drugs, 1991, Volume: 42, Issue:5 Topics: Animals; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Nausea; Neoplasms; Serotonin Antagonists; Vomiting	1991
[Gastrointestinal side effects of anticancer agents and their counter measures]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:4 Pt 2 Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Granisetron; Humans; Indazoles; Nausea; Vomiting	1990
Granisetron (BRL 43694) in the treatment of cytostatic drug-induced emesis: a summary. Cancer treatment reviews, 1990, Volume: 17, Issue:2-3 Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Ferrets; Granisetron; Headache; Humans; Indazoles; Serotonin Antagonists; Vomiting	1990
Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron. Cancer treatment reviews, 1990, Volume: 17, Issue:2-3 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Granisetron; Headache; Humans; Imidazoles; Indazoles; Indoles; Nausea; Ondansetron; Radiation Injuries; Radiotherapy; Serotonin Antagonists; Tropisetron; Vomiting	1990
Recent developments in the management of emesis with the 5-HT3 antagonist granisetron. Seminars in oncology nursing, 1990, Volume: 6, Issue:4 Suppl 1 Topics: Antiemetics; Granisetron; Humans; Indazoles; Serotonin Antagonists; Vomiting	1990

Trials

25 trial(s) available for indazoles and Emesis

Article	Year
Phase I trial of pazopanib in patients with advanced cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jun-15, Volume: 15, Issue:12 Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; Anorexia; Cohort Studies; Diarrhea; Drug Administration Schedule; Fatigue; Female; Humans; Hypertension; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Pyrimidines; Sulfonamides; Vomiting	2009
A Phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Aug-15, Volume: 17, Issue:16 Topics: Adult; Aged; Angiogenesis Inhibitors; Anorexia; Asian People; Carcinoma; Diarrhea; Drug Administration Schedule; Fatigue; Female; Humans; Indazoles; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Pyrimidines; Sulfonamides; Treatment Outcome; Vomiting	2011
A dose-finding study of granisetron, a novel antiemetic, in patients receiving cytostatic chemotherapy. The Granisetron Study Group. Journal of cancer research and clinical oncology, 1993, Volume: 119, Issue:6 Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Infant, Newborn; Injections, Intravenous; Nausea; Vomiting	1993
The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in patients receiving fractionated chemotherapy over 5 days. The Granisetron Study Group. Journal of cancer research and clinical oncology, 1993, Volume: 119, Issue:9 Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Ifosfamide; Indazoles; Male; Metoclopramide; Middle Aged; Vomiting	1993
[Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--optimal dose-finding study]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:9 Topics: Administration, Oral; Adult; Aged; Antiemetics; Cisplatin; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Vomiting	1993
[Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--multi-centered placebo-controlled double-blind comparative study]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:9 Topics: Administration, Oral; Antiemetics; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Tablets; Vomiting	1993
[Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:10 Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Granisetron; Humans; Indazoles; Lymphoma; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting	1993
[Granisetron oral phase III clinical trial--study on the inhibitory effect of granisetron for nausea/vomiting induced by chemotherapy for tumors in the hematopoietic organs]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:12 Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Granisetron; Hodgkin Disease; Humans; Indazoles; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Vomiting	1993
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:4 Topics: Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Female; Humans; Indazoles; Infusions, Intravenous; Middle Aged; Nausea; Pilot Projects; Thrombocytopenia; Treatment Outcome; Vomiting	1998
A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:6-7 Topics: Adult; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Pyrrolidines; Single-Blind Method; Vomiting	1992
A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Single-Blind Method; Vomiting	1992
Fractionated chemotherapy--granisetron or conventional antiemetics? The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1 Topics: Adult; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Nausea; Pyrrolidines; Single-Blind Method; Vomiting	1992
Oral granisetron--simple and effective: a preliminary report. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1 Topics: Administration, Oral; Adult; Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Vomiting	1992
Intravenous granisetron--establishing the optimal dose. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Vomiting	1992
A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational study. The Netherlands journal of medicine, 1992, Volume: 40, Issue:5-6 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Netherlands; Serotonin Antagonists; Vomiting	1992
A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial. European journal of cancer (Oxford, England : 1990), 1992, Volume: 29A, Issue:1 Topics: Antiemetics; Cisplatin; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Nausea; Vomiting	1992
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis. Journal of the National Cancer Institute, 1991, Aug-21, Volume: 83, Issue:16 Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Prochlorperazine; Serotonin Antagonists; Vomiting	1991
The antiemetic effect of granisetron in lower hemibody radiotherapy. Clinical oncology (Royal College of Radiologists (Great Britain)), 1991, Volume: 3, Issue:5 Topics: Aged; Antiemetics; Bone Neoplasms; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Prospective Studies; Radiotherapy; Vomiting	1991
Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic. Drugs, 1991, Volume: 42, Issue:5 Topics: Animals; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Nausea; Neoplasms; Serotonin Antagonists; Vomiting	1991
High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting. Investigational new drugs, 1990, Volume: 8, Issue:4 Topics: Antineoplastic Agents; Double-Blind Method; Drugs, Investigational; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Random Allocation; Serotonin Antagonists; Vomiting	1990
A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Time Factors; Vomiting	1990
A comparison of two dose levels of granisetron in patients receiving moderately emetogenic cytostatic chemotherapy. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Headache; Humans; Indazoles; Male; Middle Aged; Nausea; Serotonin Antagonists; Time Factors; Vomiting	1990
The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Adult; Aged; Cisplatin; Double-Blind Method; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Serotonin Antagonists; Sex Factors; Time Factors; Vomiting	1990
A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chlorpromazine; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Serotonin Antagonists; Time Factors; Vomiting	1990
Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Headache; Humans; Indazoles; Male; Metoclopramide; Middle Aged; Neoplasms; Serotonin Antagonists; Single-Blind Method; Vomiting	1990

Other Studies

39 other study(ies) available for indazoles and Emesis

Article	Year
Pazopanib-induced severe acute liver injury: A case report. Medicine, 2021, Nov-19, Volume: 100, Issue:46 Topics: Bilirubin; Biopsy; Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Female; Hepatitis B; Humans; Indazoles; Jaundice; Kidney Neoplasms; Middle Aged; Nausea; Pyrimidines; Steroids; Sulfonamides; Tomography, X-Ray Computed; Ultrasonography; United States; Vomiting	2021
Using PARP Inhibitors in Advanced Ovarian Cancer. Oncology (Williston Park, N.Y.), 2018, 07-15, Volume: 32, Issue:7 Topics: Anemia; Creatinine; Drug Administration Schedule; Drug Interactions; Exanthema; Fatigue; Female; Genes, BRCA1; Genes, BRCA2; Heart Rate; Humans; Hypertension; Indazoles; Leukopenia; Mutation; Myelodysplastic Syndromes; Nasopharyngitis; Nausea; Ovarian Neoplasms; Piperidines; Pneumonia; Poly(ADP-ribose) Polymerase Inhibitors; Thrombocytopenia; Transaminases; Vomiting	2018
A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA. The Journal of emergency medicine, 2015, Volume: 48, Issue:5 Topics: Acidosis; Adolescent; Adult; Aggression; Anxiety; Cannabinoids; Delirium; Disease Outbreaks; Female; Georgia; Humans; Hyperglycemia; Hypokalemia; Indazoles; Male; Middle Aged; Nausea; Seizures; Tachycardia; Vomiting; Young Adult	2015
Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:6 Topics: Animals; Anorexia; Antineoplastic Agents; Ataxia; Benzimidazoles; Blood Vessels; Bone Marrow; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Female; Gastrointestinal Tract; Hematologic Diseases; Indazoles; Infusions, Intravenous; Kidney Tubules; Lethargy; Macaca fascicularis; Male; Protein Kinase Inhibitors; Self Mutilation; Stereotyped Behavior; Vomiting	2008
Axitinib for the treatment of metastatic renal cell carcinoma: recommendations for therapy management to optimize outcomes. American journal of clinical oncology, 2014, Volume: 37, Issue:4 Topics: Axitinib; Carcinoma, Renal Cell; Diarrhea; Dysphonia; Fatigue; Humans; Hypertension; Imidazoles; Indazoles; Kidney Neoplasms; Nausea; Protein Kinase Inhibitors; Proteinuria; Vomiting	2014
Clinical studies with granisetron, a new 5-HT3 receptor antagonist for the treatment of cancer chemotherapy-induced emesis. The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A Suppl 1 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Constipation; Dose-Response Relationship, Drug; Female; Granisetron; Headache; Humans; Indazoles; Male; Middle Aged; Serotonin Antagonists; Vomiting	1993
Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties. European journal of pharmacology, 1993, Mar-02, Volume: 232, Issue:2-3 Topics: Animals; Antiemetics; Binding, Competitive; Cerebral Cortex; Cisplatin; Dose-Response Relationship, Drug; Ferrets; Fluoxetine; Granisetron; Indazoles; Male; Piperidines; Quipazine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Vomiting	1993
Repeated use of granisetron in patients receiving cytostatic agents. Cancer, 1993, Jun-15, Volume: 71, Issue:12 Topics: Adult; Age Factors; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Constipation; Female; Granisetron; Headache; Humans; Indazoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Remission Induction; Serotonin Antagonists; Vomiting	1993
[The prevention of CDDP-induced emesis with granisetron]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:8 Topics: Antiemetics; Cisplatin; Female; Granisetron; Humans; Indazoles; Infusions, Intravenous; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting	1993
[Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:12 Topics: Adenocarcinoma; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granisetron; Humans; Indazoles; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Nausea; Vindesine; Vomiting	1993
Pharmacokinetics and toxicity of oral and intravenous lonidamine in dogs. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:2 Topics: Administration, Oral; Animals; Antineoplastic Agents; Dogs; Indazoles; Injections, Intravenous; Kinetics; Liver; Male; Testis; Vomiting	1996
Antiemetic effects of N-3389, a newly synthesized 5-HT3 and 5-HT4 receptor antagonist, in ferrets. European journal of pharmacology, 1997, Mar-05, Volume: 321, Issue:3 Topics: 5-Methoxytryptamine; Animals; Antiemetics; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Copper Sulfate; Cyclophosphamide; Emetics; Ferrets; Indazoles; Male; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin Antagonists; Vagus Nerve; Vomiting	1997
Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides. Journal of medicinal chemistry, 1992, Mar-06, Volume: 35, Issue:5 Topics: Animals; Antiemetics; Benzamides; Benzofurans; Binding, Competitive; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Cisplatin; Ferrets; Granisetron; Imidazoles; Indazoles; Indoles; Male; Metoclopramide; Molecular Structure; Ondansetron; Rats; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Vomiting	1992
[Nausea and vomiting in chemotherapy]. Revue de l'infirmiere, 1992, Volume: 42, Issue:4 Topics: Antineoplastic Agents; Clinical Protocols; Granisetron; Humans; Indazoles; Nausea; Vomiting	1992
Dose granisetron remain effective over multiple cycles? The Granisetron Study Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Drug Administration Schedule; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Serotonin Antagonists; Sex Factors; Vomiting	1992
Are all 5-HT3 receptor antagonists the same? European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1 Topics: Animals; Antiemetics; Cisplatin; Dose-Response Relationship, Drug; Ferrets; Granisetron; Imidazoles; Indazoles; Ondansetron; Serotonin Antagonists; Vomiting; Whole-Body Irradiation	1992
Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret. British journal of pharmacology, 1992, Volume: 106, Issue:1 Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Emetics; Ferrets; Granisetron; Imidazoles; Indazoles; Injections, Subcutaneous; Morphine; Morphine Derivatives; Naloxone; Ondansetron; Vomiting	1992
The budgetary impact of 5-HT3 receptor antagonists in the management of chemotherapy-induced emesis. European journal of cancer (Oxford, England : 1990), 1992, Volume: 29A, Issue:1 Topics: Antiemetics; Antineoplastic Agents; Drug Costs; Granisetron; Humans; Indazoles; Models, Theoretical; Nausea; Ondansetron; Serotonin Antagonists; Vomiting	1992
Caring for the cancer patient: managing emesis now. An interactive workshop. Proceedings of a satellite symposium to the 6th European Conference on Clinical Oncology. Florence, October 1991. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1 Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Vomiting	1992
Who should receive a 5-HT3 antagonist? Lancet (London, England), 1992, Oct-31, Volume: 340, Issue:8827 Topics: Acute Disease; Antineoplastic Agents; Granisetron; Humans; Indazoles; Nausea; Ondansetron; Serotonin Antagonists; Vomiting	1992
5-HT3 receptor antagonist effects of DAT-582, (R) enantiomer of AS-5370. European journal of pharmacology, 1992, Jun-17, Volume: 216, Issue:3 Topics: Animals; Azepines; Bradycardia; Cisplatin; Ferrets; Guinea Pigs; Ileum; In Vitro Techniques; Indazoles; Male; Muscle Contraction; Muscle, Smooth; Rats; Serotonin Antagonists; Stereoisomerism; Vomiting	1992
Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation. Bone marrow transplantation, 1991, Volume: 7, Issue:6 Topics: Adolescent; Adult; Bone Marrow Transplantation; Female; Granisetron; Humans; Indazoles; Injections, Intravenous; Male; Middle Aged; Serotonin Antagonists; Vomiting; Whole-Body Irradiation	1991
Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:9 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Granisetron; Humans; Indazoles; Male; Nausea; Prognosis; Serotonin Antagonists; Time Factors; Vomiting	1991
Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret. European journal of pharmacology, 1991, Nov-12, Volume: 204, Issue:3 Topics: Analysis of Variance; Animals; Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Copper; Copper Sulfate; Female; Ferrets; Granisetron; Imidazoles; Indazoles; Indoles; Loperamide; Male; Ondansetron; Receptors, Serotonin; Serotonin Antagonists; Tropisetron; Vomiting	1991
Serotonin antagonists: a new class of antiemetic agents. Journal of the National Cancer Institute, 1991, May-01, Volume: 83, Issue:9 Topics: Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Granisetron; Humans; Imidazoles; Indazoles; Indoles; Metoclopramide; Ondansetron; Quinolizines; Receptors, Serotonin; Serotonin Antagonists; Tropanes; Tropisetron; Vomiting	1991
Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:2 Topics: Antiemetics; Antineoplastic Agents; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; Cisplatin; Doxorubicin; Drug Evaluation; Drug Tolerance; Granisetron; Humans; Indazoles; Nausea; Pyrazoles; Serotonin Antagonists; Vomiting	1990
Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:3 Topics: Administration, Oral; Animals; Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Defecation; Dose-Response Relationship, Drug; Ferrets; Granisetron; Indazoles; Injections, Intravenous; Male; Metoclopramide; Pyrazoles; Serotonin; Serotonin Antagonists; Vagotomy; Vomiting	1990
RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:2 Topics: Administration, Oral; Animals; Antiemetics; Antineoplastic Agents; Benzofurans; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Cisplatin; Dogs; Dopamine; Ferrets; Gastric Emptying; Granisetron; Imidazoles; Indazoles; Ondansetron; Receptors, Serotonin; Serotonin Antagonists; Vomiting	1990
The symptomatic control of cytostatic drug-induced emesis. A recent history and review. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indazoles; Serotonin Antagonists; Vomiting	1990
An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Antineoplastic Agents; Constipation; Granisetron; Headache; Humans; Indazoles; Serotonin Antagonists; Time Factors; Vomiting	1990
The role of specific 5-HT3 receptor antagonism in the control of cytostatic drug-induced emesis. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1 Topics: Animals; Antineoplastic Agents; Brain; Dose-Response Relationship, Drug; Ferrets; Granisetron; Heart Rate; Indazoles; Male; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Vomiting	1990
The conduct of clinical trials in the area of emesis control. Seminars in oncology nursing, 1990, Volume: 6, Issue:4 Suppl 1 Topics: Antiemetics; Clinical Trials as Topic; Drug Evaluation; Granisetron; Humans; Indazoles; Oncology Nursing; Vomiting	1990
A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting. Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:3 Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Tolerance; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Neoplasms; Pyrazoles; Serotonin Antagonists; Vomiting	1989
BRL 43694, a new 5HT3 receptor antagonist, prevents cisplatin-induced emesis in dogs. Methods and findings in experimental and clinical pharmacology, 1989, Volume: 11, Issue:5 Topics: Animals; Cisplatin; Dogs; Female; Granisetron; Indazoles; Male; Pyrazoles; Serotonin Antagonists; Vomiting	1989
[BRL 43694A--a 5-hydroxytryptamine receptor blocker as an antiemetic in cytostatic therapy]. Schweizerische medizinische Wochenschrift, 1989, Jun-10, Volume: 119, Issue:23 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Drug Evaluation; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Pyrazoles; Serotonin Antagonists; Vomiting	1989
BRL 43694. Cancer investigation, 1989, Volume: 7, Issue:5 Topics: Antineoplastic Agents; Granisetron; Humans; Indazoles; Pyrazoles; Serotonin Antagonists; Vomiting	1989
BRL 43694: a novel antiemetic to prevent nausea and vomiting induced by chemotherapy. Journal of the National Cancer Institute, 1988, Oct-19, Volume: 80, Issue:16 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Female; Granisetron; Humans; Indazoles; Male; Middle Aged; Nausea; Pyrazoles; Vomiting	1988
The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694. British journal of cancer, 1988, Volume: 58, Issue:5 Topics: Animals; Apomorphine; Cisplatin; Cyclophosphamide; Dogs; Doxorubicin; Ferrets; Granisetron; Indazoles; Male; Pyrazoles; Triazines; Vomiting; Whole-Body Irradiation	1988
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist. British journal of cancer, 1988, Volume: 58, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Tolerance; Female; Granisetron; Half-Life; Humans; Indazoles; Male; Middle Aged; Pilot Projects; Pyrazoles; Vomiting	1988